9-[3-[4-(4-carbazol-9-ylcarbazol-9-yl)phenyl]-5-cyanophenyl]carbazole-3,6-dicarbonitrile
C51H28N6 — CID 154959007
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-[3-[4-(4-carbazol-9-ylcarbazol-9-yl)phenyl]-5-cyanophenyl]carbazole-3,6-dicarbonitrile
9-[3-[4-(4-carbazol-9-ylcarbazol-9-yl)phenyl]-5-cyanophenyl]carbazole-3,6-dicarbonitrile (PubChem CID 154959007) has the molecular formula C51H28N6 and a molecular weight of 724.83 g/mol. Its IUPAC name is 9-[3-[4-(4-carbazol-9-ylcarbazol-9-yl)phenyl]-5-cyanophenyl]carbazole-3,6-dicarbonitrile.
Molecular Properties
| Compound Name | 9-[3-[4-(4-carbazol-9-ylcarbazol-9-yl)phenyl]-5-cyanophenyl]carbazole-3,6-dicarbonitrile |
|---|---|
| PubChem CID | 154959007 |
| Molecular Formula | C51H28N6 |
| Molecular Weight | 724.83 g/mol |
| Exact Mass | 724.24 |
| IUPAC Name | 9-[3-[4-(4-carbazol-9-ylcarbazol-9-yl)phenyl]-5-cyanophenyl]carbazole-3,6-dicarbonitrile |
| SMILES | N#Cc1cc(-c2ccc(-n3c4ccccc4c4c(-n5c6ccccc6c6ccccc65)cccc43)cc2)cc(-n2c3ccc(C#N)cc3c3cc(C#N)ccc32)c1 |
| InChI | InChI=1S/C51H28N6/c52-29-32-16-22-47-42(26-32)43-27-33(30-53)17-23-48(43)56(47)38-25-34(31-54)24-36(28-38)35-18-20-37(21-19-35)55-46-13-6-3-10-41(46)51-49(55)14-7-15-50(51)57-44-11-4-1-8-39(44)40-9-2-5-12-45(40)57/h1-28H |
| InChIKey | FIQORNYPNWIISO-UHFFFAOYSA-N |
| XLogP | 12.26 |
| TPSA | 86.16 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 57 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 724.83 |
| LogP ≤ 5 | 12.26 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154959007 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.